SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-24-000035
Filing Date
2024-05-08
Accepted
2024-05-08 16:03:39
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20240331.htm   iXBRL 10-Q 499759
2 EX-31.1 cntx2024-033110xqexhibit311.htm EX-31.1 10760
3 EX-31.2 cntx2024033110-qexhibit312.htm EX-31.2 10762
4 EX-32.1 cntx2024033110-qexhibit321.htm EX-32.1 6565
  Complete submission text file 0001842952-24-000035.txt   3189686

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20240331.xsd EX-101.SCH 25819
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20240331_cal.xml EX-101.CAL 22809
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20240331_def.xml EX-101.DEF 86788
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20240331_lab.xml EX-101.LAB 385748
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20240331_pre.xml EX-101.PRE 250501
58 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20240331_htm.xml XML 290568
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 24925778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)